Skip to content
Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Research » Peter Mac now an accredited NETs Centre of Excellence

Peter Mac now an accredited NETs Centre of Excellence

  • May 29, 2018

Fantastic
news was received recently when Prof Rod Hicks announced that the European
Neuroendocrine Tumor Society (ENETS) has given accreditation to Peter MacCallum
Cancer Centre as a “Neuroendocrine Cancer Centre of Excellence”. This is the first
centre outside of the European Union to receive this accreditation and they
have full 3-year accreditation which is a great honour and testament to the
exceptional team who always go above and beyond for their patients.

Read
Prof Rod Hick’s announcement below…

On behalf of Michael Michael and myself, I am pleased to
share this wonderful news with you all. We are very proud to be the first
centre outside the European Union to be considered for and awarded Centre of
Excellence Certification by the European Neuroendocrine Tumour Society (ENETS).
Often interim accreditation is only given for one year if there are any perceived
issues that require rectification but we have received a full 3-year
accreditation.

I would particularly like to acknowledge the huge efforts
made by Annette Hogg, Petra Marusic and David Rowe in assembling the vast
amount of performance data and coordinating the internal and external partners
involved in providing comprehensive services to our NET patients. Our
colleagues at the Royal Melbourne Hospital involved in providing excellent cardiology, endocrinology
and gastroenterology expertise are also thanked for their support and ongoing
collaboration. I will get Petra to forward this email to all those involved in
our accreditation. Finally, I extend our appreciation to Ipsen for supporting
our application through an unrestricted educational grant.

It has been a great opportunity to review our practices and
data management resources, which proved the greatest challenge, but we are now
much better placed to audit our own performance over coming years.

Thank you and congratulations to all involved. As convenor
of the Asia-Pacific Neuroendocrine Society Meeting being held in Melbourne
later this year, I hope that you will be able to join us to further showcase
the excellent clinical and research work being done in this field.

—————————————————————————————————————–

The
Unicorn Foundation’s Simone Leyden and Kate Wakelin were pleased to present to
the ENETs auditors the role of the foundation, through providing much needed
patient resources, education and support, and highlighting the important symbiotic
relationship between Centres of Excellence and NET patient organisations in
providing optimal patient outcomes.

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

World Cancer Day 2023

January 10, 2023

Support Groups Christmas Gatherings

December 20, 2022

NeuroEndocrine Cancer Australia & Norman Family Trust Partnership

December 14, 2022

NeuroEndocrine Cancer Australia partners with Gathered Here to provide the NET community with free online Wills

December 14, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNETRF announces grant funding for NETs Research
NextCancer Nurses Society of Australia Congress 2018Next

Related Posts

The Australian Cancer Plan

Shaping the future of cancer control together   We are pleased to send you this update on the Australian Cancer Plan, the first national 10-year

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Read full report

Peter MacCallum Cancer Centre – Recruiting NET health professionals for International Delphi survey

Recruiting NET health professionals for International Delphi survey Development of a neuroendocrine tumour (NET) nutrition-risk screening tool to identify patients requiring nutrition intervention and education

Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms

Read full report

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative